The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Recent developments in biased agonism
Open accessAbstract
The classic paradigm of G protein-coupled receptor (GPCR) activation was based on the understanding that agonist binding to a receptor induces or stabilizes a conformational change to an “active” conformation. In the past decade, however, it has been appreciated that ligands can induce distinct “active” receptor conformations with unique downstream functional signaling profiles. Building on the initial recognition of the existence of such “biased ligands”, recent years have witnessed significant developments in several areas of GPCR biology. These include increased understanding of structural and biophysical mechanisms underlying biased agonism, improvements in characterization and quantification of ligand efficacy, as well as clinical development of these novel ligands. Here we review recent major developments in these areas over the past several years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Self-citationAgonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G. W., & Tate, C. G. (2011) · Nature · doi:10.1038/nature10136 · Cited by 873
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Self-citationStructure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
The Dynamic Process of β2-Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Fung, J. J., Bokoch, M. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.008 · Cited by 796
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506576200 · Cited by 759
Self-citationSignalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Biased Signaling Pathways in β 2 -Adrenergic Receptor Characterized by 19 F-NMR
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., & Wüthrich, K. (2012) · Science · doi:10.1126/science.1215802 · Cited by 697
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
Self-citationStructural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647
Nobles, K. N., Xiao, K., Ahn, S., Shukla, A. K., Lam, C. M., Rajagopal, S., Strachan, R. T., Huang, T.-Y., Bressler, E. A., Hara, M. R., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001707 · Cited by 626
Self-citationMorphine Side Effects in β-Arrestin 2 Knockout Mice
Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
Warne, T., Moukhametzianov, R., Baker, J. G., Nehmé, R., Edwards, P. C., Leslie, A. G. W., Schertler, G. F. X., & Tate, C. G. (2011) · Nature · doi:10.1038/nature09746 · Cited by 618
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Self-citationStructural Basis for Molecular Recognition at Serotonin Receptors
Wang, C., Jiang, Y., Ma, J., Wu, H., Wacker, D., Katritch, V., Han, G. W., Liu, W., Huang, X.-P., Vardy, E., et al. (2013) · Science · doi:10.1126/science.1232807 · Cited by 528
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A., & Novick, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200111m · Cited by 484
Altenbach, C., Kusnetzow, A. K., Ernst, O. P., Hofmann, K. P., & Hubbell, W. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802515105 · Cited by 462
Gi protein activation in intact cells involves subunit rearrangement rather than dissociation
Bünemann, M., Frank, M., & Lohse, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536719100 · Cited by 420
Structure of class B GPCR corticotropin-releasing factor receptor 1
Hollenstein, K., Kean, J., Bortolato, A., Cheng, R. K. Y., Doré, A. S., Jazayeri, A., Cooke, R. M., Weir, M., & Marshall, F. H. (2013) · Nature · doi:10.1038/nature12357 · Cited by 416
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Rajagopal, S., Ahn, S., Rominger, D. H., Gowen-MacDonald, W., Lam, C. M., DeWire, S. M., Violin, J. D., & Lefkowitz, R. J. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072801 · Cited by 388
Self-citationStructure of the human glucagon class B G-protein-coupled receptor
Siu, F. Y., He, M., de Graaf, C., Han, G. W., Yang, D., Zhang, Z., Zhou, C., Xu, Q., Wacker, D., Joseph, J. S., et al. (2013) · Nature · doi:10.1038/nature12393 · Cited by 379
Violin, J. D., DeWire, S. M., Yamashita, D., Rominger, D. H., Nguyen, L., Schiller, K., Whalen, E. J., Gowen, M., & Lark, M. W. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173005 · Cited by 370
Coupling ligand structure to specific conformational switches in the β2-adrenoceptor
Yao, X., Parnot, C., Deupi, X., Ratnala, V. R. P., Swaminath, G., Farrens, D., & Kobilka, B. (2006) · Nature Chemical Biology · doi:10.1038/nchembio801 · Cited by 353
Kim, J., Ahn, S., Ren, X.-R., Whalen, E. J., Reiter, E., Wei, H., & Lefkowitz, R. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409532102 · Cited by 349
Self-citationRen, X.-R., Reiter, E., Ahn, S., Kim, J., Chen, W., & Lefkowitz, R. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409534102 · Cited by 331
Self-citationZidar, D. A., Violin, J. D., Whalen, E. J., & Lefkowitz, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904361106 · Cited by 278
Self-citationEnergy Landscapes as a Tool to Integrate GPCR Structure, Dynamics, and Function
Deupi, X., & Kobilka, B. K. (2010) · Physiology · doi:10.1152/physiol.00002.2010 · Cited by 264
Wootten, D., Simms, J., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221585110 · Cited by 250
Multiple ligand-specific conformations of the β2-adrenergic receptor
Kahsai, A. W., Xiao, K., Rajagopal, S., Ahn, S., Shukla, A. K., Sun, J., Oas, T. G., & Lefkowitz, R. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.634 · Cited by 250
Self-citationThe effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
Yao, X. J., Vélez Ruiz, G., Whorton, M. R., Rasmussen, S. G. F., DeVree, B. T., Deupi, X., Sunahara, R. K., & Kobilka, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811437106 · Cited by 246
Warne, T., Edwards, P. C., Leslie, A. G. W., & Tate, C. G. (2012) · Structure · doi:10.1016/j.str.2012.03.014 · Cited by 220
Rajagopal, K., Whalen, E. J., Violin, J. D., Stiber, J. A., Rosenberg, P. B., Premont, R. T., Coffman, T. M., Rockman, H. A., & Lefkowitz, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607583103 · Cited by 214
Self-citationDeciphering biased-agonism complexity reveals a new active AT1 receptor entity
Saulière, A., Bellot, M., Paris, H., Denis, C., Finana, F., Hansen, J. T., Altié, M.-F., Seguelas, M.-H., Pathak, A., Hansen, J. L., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.961 · Cited by 208
Rahmeh, R., Damian, M., Cottet, M., Orcel, H., Mendre, C., Durroux, T., Sharma, K. S., Durand, G., Pucci, B., Trinquet, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201093109 · Cited by 196
Kofuku, Y., Ueda, T., Okude, J., Shiraishi, Y., Kondo, K., Maeda, M., Tsujishita, H., & Shimada, I. (2012) · Nature Communications · doi:10.1038/ncomms2046 · Cited by 195
Busnelli, M., Saulière, A., Manning, M., Bouvier, M., Galés, C., & Chini, B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277178 · Cited by 195
G Protein Activation without Subunit Dissociation Depends on a Gαi-specific Region
Frank, M., Thümer, L., Lohse, M. J., & Bünemann, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414630200 · Cited by 180
The Structural Basis of G‐Protein‐Coupled Receptor Signaling (Nobel Lecture)
Kobilka, B. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302116 · Cited by 180
Boerrigter, G., Lark, M. W., Whalen, E. J., Soergel, D. G., Violin, J. D., & Burnett, J. C. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.962571 · Cited by 168
Kara, E., Crépieux, P., Gauthier, C., Martinat, N., Piketty, V., Guillou, F., & Reiter, E. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0098 · Cited by 166
West, G. M., Chien, E. Y. T., Katritch, V., Gatchalian, J., Chalmers, M. J., Stevens, R. C., & Griffin, P. R. (2011) · Structure · doi:10.1016/j.str.2011.08.001 · Cited by 143
The oxytocin receptor antagonist atosiban inhibits cell growth via a “biased agonist” mechanism
Reversi, A., Rimoldi, V., Marrocco, T., Cassoni, P., Bussolati, G., Parenti, M., & Chini, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409945200 · Cited by 139
First Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Soergel, D. G., Subach, R. A., Sadler, B., Connell, J., Marion, A. S., Cowan, C. L., Violin, J. D., & Lark, M. W. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.207 · Cited by 134
Boerrigter, G., Soergel, D. G., Violin, J. D., Lark, M. W., & Burnett, J. C. J. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.969220 · Cited by 130
Mary, S., Damian, M., Louet, M., Floquet, N., Fehrentz, J., Marie, J., Martínez, J., & Banères, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119881109 · Cited by 114
Koole, C., Wootten, D. L., Simms, J., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309328 · Cited by 94
Monasky, M. M., Taglieri, D. M., Henze, M., Warren, C. M., Utter, M. S., Soergel, D. G., Violin, J. D., & Solaro, R. J. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00327.2013 · Cited by 82
A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimer
Blättermann, S., Peters, L., Ottersbach, P. A., Böck, A., Kónya, V., Weaver, C. D., González, Á., Schröder, R. J., Tyagi, R., Luschnig, P., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.962 · Cited by 78
Measurements of ligand bias and functional affinity
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954-c2 · Cited by 74
Orban, T., Jastrzebska, B., Gupta, S., Wang, B., Miyagi, M., Chance, M. R., & Palczewski, K. (2012) · Structure · doi:10.1016/j.str.2012.03.017 · Cited by 67
Steen, A., Thiele, S., Guo, D. M., Gasbjerg, L. S., Frimurer, T. M., & ROSENKILDE, M. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.449587 · Cited by 64
Magnan, R., Escrieut, C., Gigoux, V., De, K., Clerc, P., Niu, F., Azéma, J., Masri, B., Cordomí, A., Baltas, M., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja308784w · Cited by 38
Jones, B. W., Song, G. J., Greuber, E. K., & Hinkle, P. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610854200 · Cited by 37
Jones, B. W., & Hinkle, P. M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045948 · Cited by 26
Abrol, R., Kim, S., Bray, J. K., Griffith, A. R., & Goddard, W. A. (2011) · Methods · doi:10.1016/j.ymeth.2011.12.005 · Cited by 19
Abrol, R., Kim, S., Bray, J. K., Trzaskowski, B., & Goddard, W. A. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391861-1.00002-2 · Cited by 18
Frey, A. J., Ibrahim, S., Gleim, S., Hwa, J., & Smyth, E. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m036673 · Cited by 16
First Human Dosing Experience with TRV130, a Biased Ligand at the Mu Opioid Receptor (P02.013)
Soergel, D. G., Subach, R. A., Violin, J. D., Yamashita, D. S., Gowen, M., & Lark, M. W. (2013) · Neurology · doi:10.1212/wnl.80.7_supplement.p02.013 · Cited by 1
Cited by
Davenport, A. P., Hyndman, K. A., Dhaun, N., Southan, C., Kohan, D. E., Pollock, J. S., Pollock, D. M., Webb, D. J., & Maguire, J. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011833 · Cited by 772
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
Self-citationStructure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography
Zhang, H., Unal, H., Gati, C., Han, G. W., Liu, W., Zatsepin, N. A., James, D., Wang, D., Nelson, G., Weierstall, U., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.011 · Cited by 382
Breaking barriers to novel analgesic drug development
Yekkirala, A. S., Roberson, D. P., Bean, B. P., & Woolf, C. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.87 · Cited by 364
Hattersley, G., Dean, T., Corbin, B. A., Bahar, H., & Gardella, T. J. (2016) · Endocrinology · doi:10.1210/en.2015-1726 · Cited by 300
Metadata
- Authors
- Wisler, J. W., Xiao, K., Thomsen, A. R., & Lefkowitz, R. J.
- Venue
- Current Opinion in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 27
- Pages
- 18-24
- ISSN
- 0955-0674 (ISSN-L)
- OpenAlex
- W1971126800
- Cited by
- 287
- References
- 61
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.